FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992170081> ?p ?o ?g. }

• W1992170081 endingPage "e11941" @default.
• W1992170081 startingPage "e11941" @default.
• W1992170081 abstract "Vascular endothelial growth factor C (VEGF-C) is a key mediator of lymphangiogenesis, acting via its receptors VEGF-R2 and VEGF-R3. High expression of VEGF-C in tumors correlates with increased lymphatic vessel density, lymphatic vessel invasion, sentinel lymph node metastasis and poor prognosis. Recently, we found that in a chemically induced skin carcinoma model, increased VEGF-C drainage from the tumor enhanced lymphangiogenesis in the sentinel lymph node and facilitated metastatic spread of cancer cells via the lymphatics. Hence, interference with the VEGF-C/VEGF-R3 axis holds promise to block metastatic spread, as recently shown by use of a neutralizing anti-VEGF-R3 antibody and a soluble VEGF-R3 (VEGF-C/D trap). By antibody phage-display, we have developed a human monoclonal antibody fragment (single-chain Fragment variable, scFv) that binds with high specificity and affinity to the fully processed mature form of human VEGF-C. The scFv binds to an epitope on VEGF-C that is important for receptor binding, since binding of the scFv to VEGF-C dose-dependently inhibits the binding of VEGF-C to VEGF-R2 and VEGF-R3 as shown by BIAcore and ELISA analyses. Interestingly, the variable heavy domain (VH) of the anti-VEGF-C scFv, which contains a mutation typical for camelid heavy chain-only antibodies, is sufficient for binding VEGF-C. This reduced the size of the potentially VEGF-C-blocking antibody fragment to only 14.6 kDa. Anti-VEGF-C VH-based immunoproteins hold promise to block the lymphangiogenic activity of VEGF-C, which would present a significant advance in inhibiting lymphatic-based metastatic spread of certain cancer types." @default.
• W1992170081 created "2016-06-24" @default.
• W1992170081 creator A5010472756 @default.
• W1992170081 creator A5020168745 @default.
• W1992170081 creator A5022959266 @default.
• W1992170081 creator A5032636721 @default.
• W1992170081 creator A5060019261 @default.
• W1992170081 date "2010-08-02" @default.
• W1992170081 modified "2023-09-26" @default.
• W1992170081 title "Phage-Derived Fully Human Monoclonal Antibody Fragments to Human Vascular Endothelial Growth Factor-C Block Its Interaction with VEGF Receptor-2 and 3" @default.
• W1992170081 cites W1513872850 @default.
• W1992170081 cites W1976984381 @default.
• W1992170081 cites W1977983409 @default.
• W1992170081 cites W1985731056 @default.
• W1992170081 cites W1985862855 @default.
• W1992170081 cites W1996976458 @default.
• W1992170081 cites W2002299335 @default.
• W1992170081 cites W2003685246 @default.
• W1992170081 cites W2007208460 @default.
• W1992170081 cites W2010897035 @default.
• W1992170081 cites W2013128795 @default.
• W1992170081 cites W2017158341 @default.
• W1992170081 cites W2025309900 @default.
• W1992170081 cites W2025933554 @default.
• W1992170081 cites W2027949644 @default.
• W1992170081 cites W2037286214 @default.
• W1992170081 cites W2037626596 @default.
• W1992170081 cites W2056392579 @default.
• W1992170081 cites W2064975896 @default.
• W1992170081 cites W2069225985 @default.
• W1992170081 cites W2073249155 @default.
• W1992170081 cites W2074534136 @default.
• W1992170081 cites W2075652170 @default.
• W1992170081 cites W2084603450 @default.
• W1992170081 cites W2089304624 @default.
• W1992170081 cites W2095553811 @default.
• W1992170081 cites W2106227707 @default.
• W1992170081 cites W2109481082 @default.
• W1992170081 cites W2110954665 @default.
• W1992170081 cites W2120521583 @default.
• W1992170081 cites W2122816413 @default.
• W1992170081 cites W2126156135 @default.
• W1992170081 cites W2133101605 @default.
• W1992170081 cites W2145884701 @default.
• W1992170081 cites W2150847879 @default.
• W1992170081 cites W2152548352 @default.
• W1992170081 cites W2155579325 @default.
• W1992170081 cites W2159137057 @default.
• W1992170081 cites W2159241628 @default.
• W1992170081 cites W2161709523 @default.
• W1992170081 cites W2171543828 @default.
• W1992170081 cites W2342432474 @default.
• W1992170081 cites W4230170474 @default.
• W1992170081 cites W4230897222 @default.
• W1992170081 cites W71022479 @default.
• W1992170081 doi "https://doi.org/10.1371/journal.pone.0011941" @default.
• W1992170081 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2914788" @default.
• W1992170081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20689828" @default.
• W1992170081 hasPublicationYear "2010" @default.
• W1992170081 type Work @default.
• W1992170081 sameAs 1992170081 @default.
• W1992170081 citedByCount "44" @default.
• W1992170081 countsByYear W19921700812012 @default.
• W1992170081 countsByYear W19921700812013 @default.
• W1992170081 countsByYear W19921700812014 @default.
• W1992170081 countsByYear W19921700812015 @default.
• W1992170081 countsByYear W19921700812016 @default.
• W1992170081 countsByYear W19921700812017 @default.
• W1992170081 countsByYear W19921700812018 @default.
• W1992170081 countsByYear W19921700812019 @default.
• W1992170081 countsByYear W19921700812020 @default.
• W1992170081 countsByYear W19921700812021 @default.
• W1992170081 countsByYear W19921700812022 @default.
• W1992170081 crossrefType "journal-article" @default.
• W1992170081 hasAuthorship W1992170081A5010472756 @default.
• W1992170081 hasAuthorship W1992170081A5020168745 @default.
• W1992170081 hasAuthorship W1992170081A5022959266 @default.
• W1992170081 hasAuthorship W1992170081A5032636721 @default.
• W1992170081 hasAuthorship W1992170081A5060019261 @default.
• W1992170081 hasBestOaLocation W19921700811 @default.
• W1992170081 hasConcept C103041312 @default.
• W1992170081 hasConcept C121608353 @default.
• W1992170081 hasConcept C146285616 @default.
• W1992170081 hasConcept C153911025 @default.
• W1992170081 hasConcept C159654299 @default.
• W1992170081 hasConcept C167734588 @default.
• W1992170081 hasConcept C181152851 @default.
• W1992170081 hasConcept C185592680 @default.
• W1992170081 hasConcept C186268636 @default.
• W1992170081 hasConcept C203014093 @default.
• W1992170081 hasConcept C2776636583 @default.
• W1992170081 hasConcept C2777025900 @default.
• W1992170081 hasConcept C2779013556 @default.
• W1992170081 hasConcept C502942594 @default.
• W1992170081 hasConcept C542903549 @default.
• W1992170081 hasConcept C54355233 @default.
• W1992170081 hasConcept C86803240 @default.
• W1992170081 hasConceptScore W1992170081C103041312 @default.

• next